{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:03:13Z","timestamp":1762671793355},"reference-count":31,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Osteoclast-mediated bone resorption plays an essential role in calcium homeostasis and lactation. The cytokine receptor activator of nuclear factor \u03baB ligand (RANKL) is one of a number of factors that controls the production, survival, and activity of osteoclasts. Calciotropic hormones, such as PTH, control RANKL transcription in part via an enhancer known as the distal control region (DCR), and mice lacking this enhancer have fewer osteoclasts under normal physiological conditions. Here, we have addressed the role of the DCR in situations in which activation of the PTH receptor is thought to stimulate bone resorption via elevation of RANKL expression. Dietary calcium deficiency stimulated RANKL expression in the bone of young (1 month old) wild-type, but not DCR knockout (KO), mice. Consistent with this, the cancellous bone loss and the increase in osteoclasts caused by dietary calcium deficiency were blunted in young KO mice. DCR deletion also prevented the increase in RANKL expression caused by dietary calcium deficiency in 6-month-old mice. However, the diet-induced bone loss was similar in wild-type and KO mice at this age. The increase in RANKL expression caused by lactation was also blunted in DCR KO mice, but lactation-induced bone loss was similar in both genotypes. These results demonstrate that, even though the DCR is required for the increase in RANKL expression associated with hyperparathyroidism or lactation, this increase is not required for the bone loss caused by these conditions in adult mice, suggesting that changes in other factors, such as osteoprotegerin or estrogen levels, play a dominant role.<\/jats:p>","DOI":"10.1210\/me.2011-1149","type":"journal-article","created":{"date-parts":[[2011,12,30]],"date-time":"2011-12-30T02:15:31Z","timestamp":1325211331000},"page":"341-348","source":"Crossref","is-referenced-by-count":24,"title":["The RANKL Distal Control Region Is Required for the Increase in RANKL Expression, But Not the Bone Loss, Associated with Hyperparathyroidism or Lactation in Adult Mice"],"prefix":"10.1210","volume":"26","author":[{"given":"Melda","family":"Onal","sequence":"first","affiliation":[{"name":"Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, and the Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Galli","sequence":"additional","affiliation":[{"name":"Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, and the Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Fu","sequence":"additional","affiliation":[{"name":"Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, and the Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhu","family":"Xiong","sequence":"additional","affiliation":[{"name":"Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, and the Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Weinstein","sequence":"additional","affiliation":[{"name":"Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, and the Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros C.","family":"Manolagas","sequence":"additional","affiliation":[{"name":"Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, and the Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"O'Brien","sequence":"additional","affiliation":[{"name":"Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences, and the Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071614161022400_B1","first-page":"S1","article-title":"Bone and plasma calcium homeostasis.","volume":"8","author":"Parfitt","year":"1987","journal-title":"Bone"},{"key":"2020071614161022400_B2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10911-005-5394-0","article-title":"Calcium and bone metabolism during pregnancy and lactation.","volume":"10","author":"Kovacs","year":"2005","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2020071614161022400_B3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev.bioeng.8.061505.095721","article-title":"Biomechanical and molecular regulation of bone remodeling.","volume":"8","author":"Robling","year":"2006","journal-title":"Annu Rev Biomed Eng"},{"key":"2020071614161022400_B4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.semcdb.2008.07.004","article-title":"Bone remodeling during fracture repair: the cellular picture.","volume":"19","author":"Schindeler","year":"2008","journal-title":"Semin Cell Dev Biol"},{"key":"2020071614161022400_B5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrg1122","article-title":"Genetic regulation of osteoclast development and function.","volume":"4","author":"Teitelbaum","year":"2003","journal-title":"Nat Rev Genet"},{"key":"2020071614161022400_B6","first-page":"115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis.","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"key":"2020071614161022400_B7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"2020071614161022400_B8","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL.","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614161022400_B9","doi-asserted-by":"crossref","first-page":"19301","DOI":"10.1074\/jbc.274.27.19301","article-title":"STAT3 activation in stromal osteoblastic cells is required for induction of the receptor activator of NF-\u03baB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D-3 or parathyroid hormone.","volume":"274","author":"O'Brien","year":"1999","journal-title":"J Biol Chem"},{"key":"2020071614161022400_B10","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1210\/endo.140.8.6887","article-title":"Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.","volume":"140","author":"Lee","year":"1999","journal-title":"Endocrinology"},{"key":"2020071614161022400_B11","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm.2448","article-title":"Matrix-embedded cells control osteoclast formation.","volume":"17","author":"Xiong","year":"2011","journal-title":"Nat Med"},{"key":"2020071614161022400_B12","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1172\/JCI29463","article-title":"Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.","volume":"116","author":"Masuyama","year":"2006","journal-title":"J Clin Invest"},{"key":"2020071614161022400_B13","doi-asserted-by":"crossref","first-page":"48868","DOI":"10.1074\/jbc.M208494200","article-title":"Parathyroid hormone stimulates receptor activator of NF\u03baB ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein.","volume":"277","author":"Fu","year":"2002","journal-title":"J Biol Chem"},{"key":"2020071614161022400_B14","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1128\/MCB.00356-06","article-title":"Parathyroid hormone controls receptor activator of NF-\u03baB ligand gene expression via a distant transcriptional enhancer.","volume":"26","author":"Fu","year":"2006","journal-title":"Mol Cell Biol"},{"key":"2020071614161022400_B15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1210\/en.2007-0734","article-title":"Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-\u03baB ligand gene reduces bone remodeling and increases bone mass.","volume":"149","author":"Galli","year":"2008","journal-title":"Endocrinology"},{"key":"2020071614161022400_B16","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1128\/MCB.00353-06","article-title":"Activation of receptor activator of NF-\u03baB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers.","volume":"26","author":"Kim","year":"2006","journal-title":"Mol Cell Biol"},{"key":"2020071614161022400_B17","first-page":"90","article-title":"Parathyroid hormone: synthesis, secretion, and action","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"Brown","year":"2006","edition":"6th ed"},{"key":"2020071614161022400_B18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.2009.05249.x","article-title":"Interactions between breast, bone, and brain regulate mineral and skeletal metabolism during lactation.","volume":"1192","author":"Wysolmerski","year":"2010","journal-title":"Ann NY Acad Sci"},{"key":"2020071614161022400_B19","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1210\/en.2006-1467","article-title":"Weaning triggers a decrease in receptor activator of nuclear factor-\u03baB ligand expression, widespread osteoclast apoptosis, and rapid recovery of bone mass after lactation in mice.","volume":"148","author":"Ardeshirpour","year":"2007","journal-title":"Endocrinology"},{"key":"2020071614161022400_B20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bone.2009.08.050","article-title":"Control of RANKL gene expression.","volume":"46","author":"O'Brien","year":"2010","journal-title":"Bone"},{"key":"2020071614161022400_B21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4049\/jimmunol.178.1.192","article-title":"Osteoprotegerin reduces the serum level of receptor activator of NF-\u03baB ligand derived from osteoblasts.","volume":"178","author":"Nakamichi","year":"2007","journal-title":"J Immunol"},{"key":"2020071614161022400_B22","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"2020071614161022400_B23","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1210\/en.2003-0892","article-title":"Low estrogen and high parathyroid hormone-related peptide levels contribute to accelerated bone resorption and bone loss in lactating mice.","volume":"144","author":"VanHouten","year":"2003","journal-title":"Endocrinology"},{"key":"2020071614161022400_B24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"2020071614161022400_B25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1210\/me.2009-0354","article-title":"The estrogen receptor-\u03b1 in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone.","volume":"24","author":"Martin-Millan","year":"2010","journal-title":"Mol Endocrinol"},{"key":"2020071614161022400_B26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor \u03b1 and induction of Fas ligand in osteoclasts.","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"key":"2020071614161022400_B27","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1210\/en.2003-1097","article-title":"Skeletal abnormalities in Pth-null mice are influenced by dietary calcium.","volume":"145","author":"Miao","year":"2004","journal-title":"Endocrinology"},{"key":"2020071614161022400_B28","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/jbmr.339","article-title":"Skeletal recovery after weaning does not require PTHrP.","volume":"26","author":"Kirby","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2020071614161022400_B29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2020071614161022400_B30","doi-asserted-by":"crossref","first-page":"E784","DOI":"10.1152\/ajpendo.00029.2005","article-title":"IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice.","volume":"289","author":"O'Brien","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071614161022400_B31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212\u0394\u0394C(T)) method.","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/26\/2\/341\/8935540\/mend0341.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/26\/2\/341\/8935540\/mend0341.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T01:48:28Z","timestamp":1594950508000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/26\/2\/341\/2614914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,1]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2011-1149","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,1]]}}}